Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Pediatric Blood & Cancer|September 26, 2008
Treating children with acute lymphoblastic leukemia and Down syndrome: pharmacokinetics provides insight into vincristine therapyClinton F Stewart
Clinical Pharmacology and Therapeutics|August 25, 2017
Development of Molecularly Targeted Therapies to Treat Pediatric MalignanciesClinton F Stewart, Giles W Robinson
Cancer Chemotherapy and Pharmacology|February 26, 2015
Response to: comment on "Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections"Karen D Wright, Clinton F Stewart
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Topoisomerase I interactive agentsMark N Kirstein, P Kellie Turner, Clinton F Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Clinical pharmacology in the adolescent oncology patientGareth J Veal, Christine M Hartford, Clinton F Stewart
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Topoisomerase I interactive agentsP Kellie Turner, Lisa C Iacono, Clinton F Stewart
Biomedical Chromatography : BMC|September 10, 2019
An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical applicationBo Zhong, Olivia Campagne, Christopher L Tinkle, et al.
Clinical Pharmacokinetics|August 25, 2006
Pharmacokinetic considerations in the treatment of CNS tumoursSusannah Motl, Yanli Zhuang, Christopher M Waters, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 19, 2017
Development and validation of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer's solution and its application to a cerebral microdialysis studyAshish Kala, Yogesh T Patel, Abigail Davis, et al.
Clinical Pharmacokinetics|December 23, 2020
Clinical Pharmacokinetics and Pharmacodynamics of SelumetinibOlivia Campagne, Kee Kiat Yeo, Jason Fangusaro, et al.
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|September 26, 2008
Treating children with acute lymphoblastic leukemia and Down syndrome: pharmacokinetics provides insight into vincristine therapyClinton F Stewart
Clinical Pharmacology and Therapeutics|August 25, 2017
Development of Molecularly Targeted Therapies to Treat Pediatric MalignanciesClinton F Stewart, Giles W Robinson
Cancer Chemotherapy and Pharmacology|February 26, 2015
Response to: comment on "Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections"Karen D Wright, Clinton F Stewart
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Topoisomerase I interactive agentsMark N Kirstein, P Kellie Turner, Clinton F Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Clinical pharmacology in the adolescent oncology patientGareth J Veal, Christine M Hartford, Clinton F Stewart
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Topoisomerase I interactive agentsP Kellie Turner, Lisa C Iacono, Clinton F Stewart
Biomedical Chromatography : BMC|September 10, 2019
An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical applicationBo Zhong, Olivia Campagne, Christopher L Tinkle, et al.
Clinical Pharmacokinetics|August 25, 2006
Pharmacokinetic considerations in the treatment of CNS tumoursSusannah Motl, Yanli Zhuang, Christopher M Waters, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 19, 2017
Development and validation of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer's solution and its application to a cerebral microdialysis studyAshish Kala, Yogesh T Patel, Abigail Davis, et al.
Clinical Pharmacokinetics|December 23, 2020
Clinical Pharmacokinetics and Pharmacodynamics of SelumetinibOlivia Campagne, Kee Kiat Yeo, Jason Fangusaro, et al.
Pageof 22